I poisoned myself with a weight-loss jab and thought I was dying. Six months later, I'm still battling a bizarre side-effect that's destroyed my willpower and made me wi…
It's been six months since I accidentally poisoned myself with a weight-loss jab I shouldn't have taken. But while the memory ...
2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious
On the other hand, the nature of its industry means that there will often be solid new reasons to be a bit more cautious ...
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
Weight-Loss injections unintentionally boost fertility, German doctors say
The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...
The Globe and Mail20h
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
Eli Lilly has an advantage. Its lineup and pipeline are more diversified than Novo Nordisk's. Though Zepbound and Mounjaro (its version of tirzepatide aimed at diabetes) are the stars of the show, the ...
The Globe and Mail22h
3 Unstoppable Stocks to Buy Right Now
One drug has been the key catalyst for Lilly: Tirzepatide. It's marketed under the brand name Mounjaro in the U.S. for treating type 2 diabetes, and under the brand name Zepbound as a weight-loss ...
True You Weight Loss Announces Two Clinical Trials Exploring Groundbreaking, Non-Surgical Weight Loss Procedures
True You Weight Loss, the nation’s first dedicated endobariatric weight loss center, today announced two new FDA-authorized clinical trials aimed at providing innovative, non-surgical solutions for ...